title: Infliximab as a steroid-sparing agent in refractory cutaneous sarcoidosis: single-center retrospective study of 9 patients.
authors.forename: Thomas
authors.initials: T
authors.lastname: Sené
authors.forename: Caroline
authors.initials: C
authors.lastname: Juillard
authors.forename: Michel
authors.initials: M
authors.lastname: Rybojad
authors.forename: Florence
authors.initials: F
authors.lastname: Cordoliani
authors.forename: Céleste
authors.initials: C
authors.lastname: Lebbé
authors.forename: Patrice
authors.initials: P
authors.lastname: Morel
authors.forename: Abdellatif
authors.initials: A
authors.lastname: Tazi
authors.forename: Fabien
authors.initials: F
authors.lastname: Guibal
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012507:Sarcoidosis / Q000188:drug therapy*; D012871:Skin Diseases / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab